Geneva, September 1st, 2022 - After almost 10 years driven by vision, passion and dedication under the leadership of Madiha Derouazi, the AMAL Therapeutics’ team has just welcomed a new CEO: Laetitia Devy Dimanche, who has taken over the role on September 1st.

Laetitia will continue to guide the Geneva site towards more successful years ahead, with the warm support of her team!